Lilly Touts New Trial Results for COVID Antibody Therapies
Indianapolis-based Eli Lilly and Co. says the combination of two of its COVID-19 antibody therapies continues to reduce hospitalizations and death in high-risk patients recently diagnosed with the dis... Read More